0.32 USD
▲+0.00+0.32%
盘后 0.35 0.00%
2026-09-16
市值
$60.34M
市盈率
—
EPS
-0.18
股息率
—
52 周区间
0.30 – 1.58
成交量
717.14K
Beta
1.61
目标价
2.00
52W 低 0.3052W 高 1.58
价格走势
公司简介
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emeto...